DK3287139T3 - Nervevækstfaktorsammensætning og injektionspulver - Google Patents
Nervevækstfaktorsammensætning og injektionspulver Download PDFInfo
- Publication number
- DK3287139T3 DK3287139T3 DK16782600.7T DK16782600T DK3287139T3 DK 3287139 T3 DK3287139 T3 DK 3287139T3 DK 16782600 T DK16782600 T DK 16782600T DK 3287139 T3 DK3287139 T3 DK 3287139T3
- Authority
- DK
- Denmark
- Prior art keywords
- growth factor
- nerve growth
- factor composition
- injection powder
- injection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510188969 | 2015-04-21 | ||
PCT/CN2016/079570 WO2016169453A1 (zh) | 2015-04-21 | 2016-04-18 | 神经生长因子组合物及注射粉剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3287139T3 true DK3287139T3 (da) | 2021-09-13 |
Family
ID=57143718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16782600.7T DK3287139T3 (da) | 2015-04-21 | 2016-04-18 | Nervevækstfaktorsammensætning og injektionspulver |
Country Status (6)
Country | Link |
---|---|
US (1) | US10576129B2 (da) |
EP (1) | EP3287139B1 (da) |
CN (1) | CN108348579B (da) |
DK (1) | DK3287139T3 (da) |
ES (1) | ES2893239T3 (da) |
WO (1) | WO2016169453A1 (da) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ226170A (en) | 1987-09-18 | 1990-07-26 | Ethicon Inc | Stable freeze-dried pharmaceutical composition containing epidermal growth factor |
US6277828B1 (en) | 1993-08-20 | 2001-08-21 | Syntex (U.S.A.) Inc. | Pharmaceutical formulations of nerve growth factor |
PT2275119E (pt) | 1995-07-27 | 2013-11-21 | Genentech Inc | Formulação de proteína liofilizada isotónica estável |
US6090781A (en) | 1996-11-06 | 2000-07-18 | Genentech, Inc. | Stabilizing formulation for NGF |
JP4057058B2 (ja) * | 1995-11-07 | 2008-03-05 | ジェネンテック インコーポレーテッド | Ngfの安定化処方 |
PT1820516E (pt) | 1999-02-22 | 2013-10-31 | Baxter Int | Novas formulações de factor viii isentas de albumina |
NZ529856A (en) * | 1999-10-04 | 2005-09-30 | Chiron Corp | Stabilized liquid polypeptide-containing pharmaceutical compositions |
ES2338218T3 (es) | 2001-07-25 | 2010-05-05 | Facet Biotech Corporation | Formulacion farmacologica liofilizada estable de anticuerpos igg daclizumab. |
CN1318087C (zh) | 2003-06-06 | 2007-05-30 | 北京三诺佳邑生物技术有限责任公司 | 去白蛋白神经生长因子制剂 |
WO2006014965A2 (en) | 2004-07-27 | 2006-02-09 | Human Genome Sciences, Inc. | Pharmaceutical formulation and process |
JP2007131586A (ja) | 2005-11-11 | 2007-05-31 | Staidson (Beijing) Pharmaceutical Co Ltd | 体重を減らすことができる有用な医薬品製剤における神経成長因子(ngf)の使用 |
CN1843503A (zh) | 2006-01-25 | 2006-10-11 | 安徽金大陆生物制药有限公司 | 一种滴眼剂 |
CN1857718A (zh) | 2006-03-22 | 2006-11-08 | 安徽金大陆生物制药有限公司 | 一种神经生长因子注射剂 |
TW200831129A (en) | 2006-10-06 | 2008-08-01 | Amgen Inc | Stable formulations |
EP2144624A1 (en) | 2007-05-15 | 2010-01-20 | Stryker Corporation | Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof |
CN101613394B (zh) | 2008-06-27 | 2012-07-18 | 厦门北大之路生物工程有限公司 | 鼠神经生长因子的制备方法和注射用鼠神经生长因子的制备方法 |
WO2010148321A1 (en) * | 2009-06-18 | 2010-12-23 | Wyeth Llc | Slow dissolution method for reconstitution of lyophilized material |
CN101972470B (zh) * | 2010-09-13 | 2012-10-17 | 舒泰神(北京)生物制药股份有限公司 | 一种眼用原位凝胶 |
-
2016
- 2016-04-18 ES ES16782600T patent/ES2893239T3/es active Active
- 2016-04-18 US US15/568,453 patent/US10576129B2/en active Active
- 2016-04-18 CN CN201680023083.3A patent/CN108348579B/zh active Active
- 2016-04-18 DK DK16782600.7T patent/DK3287139T3/da active
- 2016-04-18 WO PCT/CN2016/079570 patent/WO2016169453A1/zh active Application Filing
- 2016-04-18 EP EP16782600.7A patent/EP3287139B1/en not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
WO2016169453A1 (zh) | 2016-10-27 |
CN108348579B (zh) | 2021-04-27 |
CN108348579A (zh) | 2018-07-31 |
EP3287139B1 (en) | 2021-08-11 |
US10576129B2 (en) | 2020-03-03 |
ES2893239T3 (es) | 2022-02-08 |
EP3287139A1 (en) | 2018-02-28 |
US20180104310A1 (en) | 2018-04-19 |
EP3287139A4 (en) | 2018-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251153A1 (zh) | 一種藥物組合物及其應用 | |
GB2546350B (en) | Compositions and methods | |
ZA201805064B (en) | Hair growth composition and method | |
DK3169741T3 (da) | Forbedrede bindemiddelsammensætninger og anvendelser deraf | |
ZA201608046B (en) | Pesticidal compositions and related methods | |
DK3018183T3 (da) | Halogenolefinbaseret sammensætning og anvendelse deraf | |
DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
HK1258704A1 (zh) | 藥物組合物和塗料 | |
IL253538B (en) | Heterocyclic compound and pharmaceutical compound containing it | |
HK1243354B (zh) | 新穎碘伏組合物及其使用方法 | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
HK1254749A1 (zh) | 睫毛膏組合物和方法 | |
HK1254746A1 (zh) | 睫毛膏組合物和方法 | |
HK1254747A1 (zh) | 睫毛膏組合物和方法 | |
DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
HK1257421A1 (zh) | Bag3 組合物和方法 | |
DK3166960T3 (da) | Lav-substituerede polymyxiner og sammensætninger deraf | |
PL3349594T3 (pl) | Kompozycja zastępująca sól i jej zastosowanie | |
DK3287140T3 (da) | Nervevækstfaktorsammensætning og pulverinjektion | |
HK1254750A1 (zh) | 睫毛膏組合物和方法 | |
IL248863A0 (en) | Preparations containing il-31 and their use | |
GB201512996D0 (en) | Compositions and methods | |
GB201401706D0 (en) | Nanoparticle-insulin and insulin analogue compositions | |
ZA201801745B (en) | Biocides and preparation thereof | |
GB201703975D0 (en) | Composition and methods |